Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from European Medicines Agency

06:41 EDT 15th August 2018 | BioPortfolio

Here are the most relevant search results for "European Medicines Agency" found in our extensive news archives from over 250 global news sources.

More Information about European Medicines Agency on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about European Medicines Agency for you to read. Along with our medical data and news we also list European Medicines Agency Clinical Trials, which are updated daily. BioPortfolio also has a large database of European Medicines Agency Companies for you to search.

Showing News Articles 1–25 of 4,900+ from European Medicines Agency

Tuesday 14th August 2018

Human medicines European public assessment report (EPAR): Galafold, migalastat, Revision: 6, Authorised

Human medicines European public assessment report (EPAR): Inlyta, axitinib, Revision: 8, Authorised

Veterinary medicine European public assessment report (EPAR): Ubac, Streptococcus uberis vaccine (inactivated), Revision: 0, Authorised

Human medicines European public assessment report (EPAR): Darunavir Mylan, darunavir, Revision: 2, Authorised

Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Revision: 11, Authorised

Veterinary medicine European public assessment report (EPAR): Sileo, dexmedetomidine, Revision: 6, Authorised

Veterinary medicine European public assessment report (EPAR): Suvaxyn PRRS MLV, Porcine respiratory and reproductive syndrome virus vaccine (live), Revision: 2, Authorised

Human medicines European public assessment report (EPAR): Otezla, apremilast, Revision: 5, Authorised

Monday 13th August 2018

Human medicines European public assessment report (EPAR): Stocrin, efavirenz, Revision: 39, Authorised

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Revision: 40, Authorised

Human medicines European public assessment report (EPAR): Aldara, imiquimod, Revision: 24, Authorised

Veterinary medicine European public assessment report (EPAR): Onsior, robenacoxib, Revision: 11, Authorised

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Revision: 9, Authorised

Human medicines European public assessment report (EPAR): Tybost, cobicistat, Revision: 11, Authorised

Human medicines European public assessment report (EPAR): PecFent, fentanyl, Revision: 17, Authorised

Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Revision: 20, Authorised

Friday 10th August 2018

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Revision: 27, Authorised

Human medicines European public assessment report (EPAR): Sevelamer carbonate Zentiva, sevelamer carbonate, Revision: 10, Authorised

Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Revision: 22, Authorised

Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Revision: 16, Authorised

News and press releases: Update on review of valsartan medicines due to detection of NDMA

EMA reviewing valsartan produced by another company Zhejiang Tianyu

Human medicines European public assessment report (EPAR): Exforge HCT, amlodipine besylate / valsartan / hydrochlorothiazide, Revision: 13, Authorised

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Revision: 13, Authorised

Human medicines European public assessment report (EPAR): Riximyo, rituximab, Revision: 2, Authorised

Human medicines European public assessment report (EPAR): Genvoya, elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide, Revision: 16, Authorised


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks